NPPA Extends Knee Implant Price Cap to 2027

The National Pharmaceutical Pricing Authority (NPPA) extended the validity of ceiling prices for orthopaedic knee implants until 15 January 2027. The Ministry of Chemicals and Fertilizers issued the notification on 13 November 2026.

Price cap and its extension

The ceiling prices were first notified on 16 August 2017 through S.O. 2668(E). An earlier order, S.O. 5190(E), dated 14 November 2025, extended them until 15 November 2026. The provisions and notes (b) to (t) of the 2017 notification remain in force during the latest extension.

Manufacturer data submission

The NPPA considered representations from manufacturers and industry associations on the price cap. The extension aims to support affordability and access for patients and maintain uniform pricing across the healthcare sector. In September 2026, the NPPA also directed knee implant manufacturers and importers to submit relevant data through the Knee Implant Data Collection module on the IPDMS 2.0 Portal by 30 September 2026.

Important Facts for Exams

• DPCO enforcement: The NPPA implements and enforces the Drugs (Prices Control) Order using powers delegated to it.
• Supply monitoring: The NPPA monitors medicine availability, identifies shortages and takes remedial steps.
• Market data: For bulk drugs and formulations, the NPPA maintains data on production, exports, imports, company market shares and profitability.